These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15254599)

  • 21. Mid-urethral sling operations for stress urinary incontinence in women.
    Ford AA; Rogerson L; Cody JD; Ogah J
    Cochrane Database Syst Rev; 2015 Jul; (7):CD006375. PubMed ID: 26130017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women.
    Ayeleke RO; Hay-Smith EJ; Omar MI
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010551. PubMed ID: 24259154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression.
    Mallinckrodt CH; Goldstein DJ; Detke MJ; Lu Y; Watkin JG; Tran PV
    Prim Care Companion J Clin Psychiatry; 2003 Feb; 5(1):19-28. PubMed ID: 15156243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of efficacy of duloxetine in stress urinary incontinence in women.
    Deepak P; Kumar TN; Sen TK
    Indian J Pharmacol; 2011 Apr; 43(2):176-9. PubMed ID: 21572653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolapse surgery with or without stress incontinence surgery for pelvic organ prolapse: a systematic review and meta-analysis of randomised trials.
    van der Ploeg JM; van der Steen A; Oude Rengerink K; van der Vaart CH; Roovers JP
    BJOG; 2014 Apr; 121(5):537-47. PubMed ID: 24382099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Midurethral Fascial "Sling on a String": An Alternative to Midurethral Synthetic Tapes in the Era of Mesh Complications.
    Osman NI; Hillary CJ; Mangera A; Aldamanhoori R; Inman RD; Chapple CR
    Eur Urol; 2018 Aug; 74(2):191-196. PubMed ID: 29803585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence.
    Bent AE; Gousse AE; Hendrix SL; Klutke CG; Monga AK; Yuen CK; Muram D; Yalcin I; Bump RC
    Neurourol Urodyn; 2008; 27(3):212-21. PubMed ID: 17580357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duloxetine treatment of stress urinary incontinence in women: effects of demographics, obesity, chronic lung disease, hypoestrogenism, diabetes mellitus, and depression on efficacy.
    Viktrup L; Yalcin I
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):105-13. PubMed ID: 16769171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence.
    Ghoniem GM; Van Leeuwen JS; Elser DM; Freeman RM; Zhao YD; Yalcin I; Bump RC;
    J Urol; 2005 May; 173(5):1647-53. PubMed ID: 15821528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.
    Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB
    Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary retention during combined treatment of postpsychotic depression with duloxetine and olanzapine.
    Englisch S; Fritzinger M; Zink M
    Clin Neuropharmacol; 2008; 31(5):307-9. PubMed ID: 18836353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observational study on safety and tolerability of duloxetine in the treatment of female stress urinary incontinence in German routine practice.
    Michel MC; Minarzyk A; Schwerdtner I; Quail D; Methfessel HD; Weber HJ
    Br J Clin Pharmacol; 2013 Apr; 75(4):1098-108. PubMed ID: 22816871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duloxetine in treatment of anxiety symptoms associated with depression.
    Dunner DL; Goldstein DJ; Mallinckrodt C; Lu Y; Detke MJ
    Depress Anxiety; 2003; 18(2):53-61. PubMed ID: 12964171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorder.
    Emslie GJ; Wells TG; Prakash A; Zhang Q; Pangallo BA; Bangs ME; March JS
    J Child Adolesc Psychopharmacol; 2015 May; 25(4):293-305. PubMed ID: 25978741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression.
    Detke MJ; Lu Y; Goldstein DJ; McNamara RK; Demitrack MA
    J Psychiatr Res; 2002; 36(6):383-90. PubMed ID: 12393307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study.
    Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Hann D; Marangell LB
    Curr Med Res Opin; 2011 Oct; 27(10):1859-67. PubMed ID: 21838410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
    Shelton RC; Prakash A; Mallinckrodt CH; Wohlreich MM; Raskin J; Robinson MJ; Detke MJ
    Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine.
    Rodrigues-Amorim D; Olivares JM; Spuch C; Rivera-Baltanás T
    Front Psychiatry; 2020; 11():554899. PubMed ID: 33192668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.
    Greist J; McNamara RK; Mallinckrodt CH; Rayamajhi JN; Raskin J
    Clin Ther; 2004 Sep; 26(9):1446-55. PubMed ID: 15531007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.
    Drake MJ; Chapple C; Sokol R; Oelke M; Traudtner K; Klaver M; Drogendijk T; Van Kerrebroeck P;
    Eur Urol; 2015 Feb; 67(2):262-70. PubMed ID: 25070148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.